Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular disease within the next 30 years, according to two new science reports from the American Heart Association (AHA).

News | AHA

Heart Disease and Stroke Could Affect at Least 60% of Adults in U.S. by 2050, According to American Heart Association Advisories

June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. population could be affected by cardiovascular ...

June 18, 2024

Medical device company Visura Technologies, Inc. has announced the TEECADE mini, an initiative for the next innovation in transesophageal echocardiography (TEE) imaging technology. The company, led by President & CEO Christine Horton, will be participating in the American Society of Echocardiography Scientific Sessions (ASE 2024) to be held June 14-16 in Portland, OR.

News | Transesophageal Echo (TEE)

Visura Technologies to Feature TEECAD mini for Use with Smaller Transesophageal Echocardiography (TEE) Probes During ASE 2024

June 13, 2024 — Visura Technologies, Inc., a privately owned medical device company, has announced the TEECADE mini, an ...

June 13, 2024

Royal Philips has announced its AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology, reporting that results of a new scientific abstract being presented at the American Society of Echocardiography (ASE 2024) annual meeting, June 14-16 in Portland, OR, will demonstrate how first-of-kind AI algorithms co-developed with Philips provide highly accurate detection of regional wall motion abnormalities (RWMA) on echocardiography.

News | ASE

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help ...

June 12, 2024

A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis

News | SPECT-CT

Novel Radiotracer Produces High Quality Images of “Alzheimer’s Disease of the Heart”

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

June 11, 2024

A Review of the 2024 Heart Rhythm Society Conference

Feature | HRS | By Lars Thording, PhD

HRS 2024: Innovation Meets Reality

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient ...

June 11, 2024

New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously published qualitative and semi-quantitative measurements

News | Cardiac Imaging

New Expert Consensus Turns Cardiac CT Imaging into Measurable Standards

June 10, 2024 — New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously ...

June 10, 2024

Xylitol is a common zero-calorie sweetener found in sugar-free candy and toothpaste

News | Hypertension

Study: Young Athletes at Risk for Elevated Blood Pressure Rates, Future Cardiovascular Complications

June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at ...

June 06, 2024

Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1

News | Pharmaceuticals

New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

June 05, 2024

The 35th Annual ASE Scientific Sessions, will be held June 14-16, at the Oregon Convention Center in Portland, OR, with an expansive program focused on “Global Echocardiography: Innovations in Diagnosis and Beyond.”

Feature | ASE | Christine Book

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific ...

June 04, 2024

DESyne BDS Plus system with site-specific antithrombotic therapeutic (TRx) significantly reduced the risk of TLF versus conventional drug-eluting stent through 12-months

News | Cardiovascular Clinical Studies

Elixir Medical’s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES

June 3, 2024 — Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease ...

June 03, 2024

Conference focuses on rapidly expanding field of sports cardiology and increasing demand for CV care teams who care for athletes

News | Cardiovascular Education

American College of Cardiology Announces Care of the Athletic Heart

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

May 31, 2024

Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan.

News | EuroPCR

Elixir Medical PINNACLE I Study of LithiX IVL System Meets Primary Endpoints of Clinical Success

May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced ...

May 30, 2024

Data was presented today byAstraZeneca, at the European Atherosclerosis Society (EAS) Congress in France,on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL-C reduction on top of statin in Phase I trial.

News | Cardiovascular Clinical Studies

Oral PCSK9 Inhibitor Demonstrated Significant LDL-C Reduction on Top of Statin in Phase I Trial Presented at EAS Congress

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

May 29, 2024

Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024

News | Heart Failure

Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

May 28, 2024

The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading.

News | AHA

American Heart Association Warns of Misinformation Connecting COVID Vaccination to Heart Defects

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

May 24, 2024